Renal cell carcinoma (RCC) incidence is increasing worldwide. Here, the authors consider the potential benefits and harms of screening for RCC and discuss whether enough evidence is available to begin a clinical trial of RCC screening.
- Juliet Usher-Smith
- Rebecca K. Simmons
- Grant D. Stewart